₹ 552.65
19.75 (3.71%)Open
534.7High
560.85Low
530.25Prev Close
532.9P/E
-Median P/E
31.46P/B
1.28Median P/B
4.43Market Cap
19.89BPEG
-Div.Yield
-Bid
-Ask
-Large Cap
19.89B Mkt. Cap.Volatility
-Beta
1.22Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 545.25 | 544.86 |
10 | 498.58 | 498.16 |
20 | 453.69 | 453.46 |
50 | 431.43 | 431.28 |
100 | 403.85 | 403.79 |
300 | 380.85 | 380.83 |
BSE
541540NSE
SOLARAISIN
INE624Z01016Solara Active Pharma Sciences Limited is an India-based company offering diversified, commercial active pharmaceutical ingredients (APIs) and contract manufacturing services in over 70 countries. The Company operates through the API segment. Its commercial and research and development products include Albendazole, Aprepitant (Antiemetic), Artesunate, Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Antitubercular), Ethacrynic Acid (Cardiovascular Agent), Hydralazine Hydrochloride (Anti-Hypertensive), Ibuprofen Sodium Dihydrate (Anti-inflammatory), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (OAB Treatment), Pentoxifylline, and others. The Company works with pharmaceutical companies from North America, Europe, and Japan.
Poorvank Purohit
Chief Executive Officer, Managing Director, DirectorArun Baskaran
Chief Financial OfficerM. Mohan
Chief Operating Officer, Additional Executive DirectorRajeev Singh
Chief Human Resource OfficerSudhir Nambiar
Chief Scientific Officer (Head R&D)S. Murali Krishna
Compliance Officer, Company SecretaryV. Sundara Moorthy
Chief Quality Officer